These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16339499)

  • 1. Platelet inhibition by insulin is absent in type 2 diabetes mellitus.
    Ferreira IA; Mocking AI; Feijge MA; Gorter G; van Haeften TW; Heemskerk JW; Akkerman JW
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):417-22. PubMed ID: 16339499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
    Goto S; Tamura N; Ishida H; Ruggeri ZM
    J Am Coll Cardiol; 2006 Jan; 47(1):155-62. PubMed ID: 16386680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.
    Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P
    Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the purinergic receptor P2Y12 potentiates platelet shape change by a Rho kinase-dependent mechanism.
    Hardy AR; Hill DJ; Poole AW
    Platelets; 2005 Nov; 16(7):415-29. PubMed ID: 16236603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties?
    Baurand A; Eckly A; Hechler B; Kauffenstein G; Galzi JL; Cazenave JP; Léon C; Gachet C
    Mol Pharmacol; 2005 Mar; 67(3):721-33. PubMed ID: 15602005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): in vitro effects on platelets.
    Bryant J; Post JM; Alexander S; Wang YX; Kent L; Schirm S; Tseng JL; Subramanyam B; Buckman B; Islam I; Yuan S; Sullivan ME; Snider M; Morser J
    Thromb Res; 2008; 122(4):523-32. PubMed ID: 18495218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity.
    Leon C; Ravanat C; Freund M; Cazenave JP; Gachet C
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1941-7. PubMed ID: 12933533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual P2Y 12 receptor signaling in thrombin-stimulated platelets--involvement of phosphoinositide 3-kinase beta but not gamma isoform in Ca2+ mobilization and procoagulant activity.
    van der Meijden PE; Schoenwaelder SM; Feijge MA; Cosemans JM; Munnix IC; Wetzker R; Heller R; Jackson SP; Heemskerk JW
    FEBS J; 2008 Jan; 275(2):371-85. PubMed ID: 18081863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways.
    Shen J; DiCorleto PE
    Circ Res; 2008 Feb; 102(4):448-56. PubMed ID: 18174464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
    Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
    Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function.
    Judge HM; Buckland RJ; Sugidachi A; Jakubowski JA; Storey RF
    Thromb Haemost; 2010 Jun; 103(6):1210-7. PubMed ID: 20431852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.
    Wong PC; Crain EJ; Watson CA; Jiang X; Hua J; Bostwick JS; Ogletree ML; Schumacher WA; Rehfuss R
    J Cardiovasc Pharmacol; 2007 May; 49(5):316-24. PubMed ID: 17513951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets Express Activated P2Y
    Hu L; Chang L; Zhang Y; Zhai L; Zhang S; Qi Z; Yan H; Yan Y; Luo X; Zhang S; Wang Y; Kunapuli SP; Ye H; Ding Z
    Circulation; 2017 Aug; 136(9):817-833. PubMed ID: 28637879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability.
    van Gestel MA; Heemskerk JW; Slaaf DW; Heijnen VV; Reneman RS; oude Egbrink MG
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):518-23. PubMed ID: 12615691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased platelet purinergic sensitivity in peripheral arterial disease--a pilot study.
    Braun OO; Jagroop A; Wang L; Mikhailidis DP; Burnstock G; Erlinge D
    Platelets; 2005 Aug; 16(5):261-7. PubMed ID: 16011976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3-kinase is essential for ADP-stimulated integrin alpha(IIb)beta3-mediated platelet calcium oscillation, implications for P2Y receptor pathways in integrin alpha(IIb)beta3-initiated signaling cross-talks.
    Sun DS; Lo SJ; Tsai WJ; Lin CH; Yu MS; Chen YF; Chang HH
    J Biomed Sci; 2005 Dec; 12(6):937-48. PubMed ID: 16228296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: a new finding that may influence the design of anti-thrombotic agents.
    Manolopoulos P; Glenn JR; Fox SC; May JA; Dovlatova NL; Tang SW; Thomas NR; Ralevic V; Heptinstall S
    Platelets; 2008 Mar; 19(2):134-45. PubMed ID: 18297551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.